Starkage Therapeutics is a biotechnology company that aims to delay and improve quality of life of patients with age-related diseases.
Starkage Therapeutics has raised $1.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Starkage Therapeutics's investors include Bpifrance.
Starkage Therapeutics is headquartered in Lille, France.
Starkage Therapeutics is a biotechnology company that aims to delay and improve quality of life of patients with age-related diseases.
Starkage Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Starkage Therapeutics — Funding & Investors." VCBacked, May 29, 2024, https://www.vcbacked.co/company/starkage-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Starkage Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/starkage-therapeutics
{{cite web |title=Starkage Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/starkage-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated